当前位置:
X-MOL 学术
›
Diagn. Microbiol. Infect. Dis.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Update on the in vitro activity of dalbavancin against indicated species (Staphylococcus aureus, Enterococcus faecalis, β-hemolytic streptococci, and Streptococcus anginosus group) collected from United States hospitals in 2017–2019
Diagnostic Microbiology and Infectious Disease ( IF 2.9 ) Pub Date : 2020-08-28 , DOI: 10.1016/j.diagmicrobio.2020.115195 Helio S Sader 1 , Jennifer M Streit 1 , Rodrigo E Mendes 1
中文翻译:
2017-2019年从美国医院收集的达巴万星对所示种(金黄色葡萄球菌,粪肠球菌,β-溶血性链球菌和链球菌链球菌组)的体外活性更新
更新日期:2020-09-22
Diagnostic Microbiology and Infectious Disease ( IF 2.9 ) Pub Date : 2020-08-28 , DOI: 10.1016/j.diagmicrobio.2020.115195 Helio S Sader 1 , Jennifer M Streit 1 , Rodrigo E Mendes 1
Affiliation
This study updates dalbavancin activity against contemporary (2017–2019) isolates of indicated species/groups (n = 16,451). Isolates from 71 hospitals were tested by broth microdilution method. All isolates were susceptible to dalbavancin. Dalbavancin MIC50/90 values remained stable for Staphylococcus aureus, vancomycin-susceptible Enterococcus faecalis, β-hemolytic streptococci, and Streptococcus anginosus group since its clinical approval.
中文翻译:
2017-2019年从美国医院收集的达巴万星对所示种(金黄色葡萄球菌,粪肠球菌,β-溶血性链球菌和链球菌链球菌组)的体外活性更新
这项研究更新了达巴万星对当代(2017-2019)所示种/群的分离物的活性(n = 16,451)。通过肉汤微稀释法测试了来自71家医院的分离株。所有分离株均对达巴万星敏感。自临床批准以来,金黄色葡萄球菌,易感万古霉素的粪便肠球菌,β-溶血性链球菌和链球菌链球菌的达巴万星MIC 50/90值保持稳定。